Gerard Cassidy, RBC Capital Markets analyst, provides a preview of what to expect when big banks report earnings this quarter.
A look at what traders are watching ahead of the markets' open, with Kevin Ferry, Cronus Futures Management.
CNBC's Kelly Evans reports European stocks shrugged off weak economic data and marched higher in today's market action.
CNBC's Kelly Evans tells you what the markets will be watching as we approach the start of trading in the U.S.
Pipelines have been the dominant group in the last few sessions, and yesterday the bulls came back to Oneok.
India's Finance Minister P. Chidambaram tells CNBC why the case for foreign investment in India is a solid one, despite economic headwinds and a depreciating rupee.
Malcolm Jones, Investment Director, Asia-Pacific at Standard Life Investments, enumerates three points for the long-term investor in Japan.
It's no April Fool's Day joke. Drivers are indeed paying less to fill up their gas tanks than they did a few weeks ago, a month ago, a year ago.
Stocks ended the first trading day of Q2 in the red. CNBC's Seema Mody; Jim LaCamp, UBS; and Lee Munson, Portfolio Asset Management, discuss how to invest in April.
Michael Dell sent a message to Dell employees Monday making his case for his intended buyout of the company with private equity firm Silver Lake Partners.
Jim Cramer identifies two stocks among the 10 biggest S&P 500 first quarter losers that he thinks are bargains.
Discussing the similarities between Enbridge and American Water Works, and why Enbridge might make a better buy, with Mad Money host Jim Cramer.
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
Which leaders might continue to drive the market in Q2. Cramer crunched the numbers.
Mad Money host Jim Cramer discusses which stocks have the potential to power higher in Q2.
Looking for a small stock with big return potential? Jim Cramer thinks you should consider this.
There is a whole new generation of drug companies ready to take on what big pharma was in the '90s, says Mad Money host Jim Cramer. A close look at speculative drug stocks, including Alexion and BioMarin.
If management listens to Cramer, these 10 stocks could have some serious upside.
Focus on individual companies, and what they're doing to bring out value, explains Mad Money host Jim Cramer.
Mad Money host and former hedge fund manager, Jim Cramer, provides stock traders with all manner of investing advice.